48Hour Discovery of Chemically-modified Peptide Ligands
Ratmir Derda
Ratmir, University of Alberta // 48Hour Discovery, Inc.
48Hour Discovery Inc. is a Canadian start-up company providing services in ligand discovery using an unprecedented turnaround time at a manageable cost. Founded in February 2017, our core business is rooted in our patented molecular discovery platform emanating from the expertise and IP generated by the Derda Research Group the University of Alberta. The company will provide chemical structures of chemically-modified peptide ligands—a list of 50–100 confident leads—within 48 hours of the receipt of the target by the company. We use genetically-encoded (GE)-libraries of peptides as a starting material for multi-step organic synthesis to produce GE-libraries of peptide derivatives. Genetically-Encoded Discovery platform (3), combines 10^8 peptide fragments with variable, silently-encoded modifications(4). The presentation will highlight the advances in application of our discovery platform to non-druggable targets such as carbohydrate binding proteins and technologies we developed not only to accelerate discovery but also maximize the reproducibility of discovery.
References
1. (a) J. Am. Chem. Soc., 2014, 136, 8149. (b) ACS Chem. Biol., 2012, 7, 1482
2. (a) ACS Chem. Biol., 2014, 9, 443. (b) Chem. Sci., 2016, 7, 3785. (c) Org. Biomol. Chem., 2016, 14, 5539-5545.
3. Ng et al., J. Am. Chem. Soc., 2015, 137, 5248
4. Tjhung et al., J. Am. Chem. Soc., 2016, 138, 32.
Ratmir Derda received his undergraduate degree in Physics from Moscow Institute of Physics and Technology in 2001, Ph.D. in Chemistry from the University of Wisconsin-Madison in 2008, under the supervision of Laura L. Kiessling, and postdoctoral training at Harvard University under the supervision of George M. Whitesides and Donald E. Ingber. He joined University of Alberta in 2011 as an Assistant Professor in Chemistry. In 2012, he became a principal investigator at the Alberta Glycomics Centre. Derda lab develops genetically-encoded libraries to solve fundamental problems in chemical reactivity, molecular recognition and cell differentiation. Notable awards include Rising Star in Chemical Biology from the International Chemical Biology Society (2016); Young Investigator Award from the Boulder Peptide Society (2014); Canadian Rising Star in Global Health (2011).
The Boulder Peptide Foundation was established to further the science and knowledge of peptide technology to develop novel therapeutics, biomaterials, medical diagnostics and other beneficial uses for mankind. As part of this goal we run several programs to support career advancement, seminars and educational events. Join us on our mission to expand the applications of peptide science.
The purpose of the Boulder Peptide Symposium is to encourage sharing of information related to peptide therapeutic development with an emphasis on the technical, scientific and regulatory aspects of the pharmaceutical development. Presentations that demonstrate original thinking or share experiences from case studies in product development shall receive priority over others.
The Boulder Peptide Symposium offers multiple opportunities for participants to present.
The session topics for Scientific Program are Peptides in the Clinic, Drug Delivery, Chemistry of Complex Peptides, Spotlight on Discovery, and Peptide Showcase. Abstracts may be submitted via the Apply to Present page on the website. Submissions will be reviewed by the Scientific Advisory Board on a monthly basis and the speaker will be notified of a decision.
Presentation length: Format is 25-30 minutes slide presentation with 5-10 minutes for Q&A, with the exception of Peptide Showcase talks which are 10 minute slide presentations with 5 minutes for Q&A. Please confirm with your session chair to confirm the exact presentation length.
Invited Speakers: Speakers are requested to supply their presentation details 30 days after receiving an invitation to present.
Program Book Deadline: Final abstract and title must be provided no later than September 1st. No changes to the program are possible after this date.
Presentation Format: Oral presenters please provide your presentation slides to the A/V table on the day of your presentation.
Lodging: All speakers are requested to reserve their own room. Discount rates at the conference hotel are available until August 16th.
Registration: All speakers, excluding sponsored presentation speakers, receive a complimentary registration upon approval of the abstract.
The Peptide Showcase is an opportunity for an individual or company to “showcase” new ideas, technology and pipeline assets. Priority shall be given to presentations from biotech and startup companies. Service providers and vendors are not eligible. Speakers in the session receive a complimentary event registration.
Posters can be presented on any topic relevant to peptides including original research, innovative products and technologies.
Eligibility- Any attendee (from academia, industry, biotech or vendor/sponsor) can present a poster. The presentation must contain original scientific thinking. To submit a poster go to the Submit a Poster link from the meeting menu. All submissions are reviewed on a rolling basis and will be notified of approval. September 1st is the last day to submit a poster abstract. Approved posters are published on the BPF website.
A 30 ” x 40″ board shall be provided with thumb tacks. Board will be on an easel and can be rotated for either landscape or portrait formats. Once you apply for a poster, you will get email confirmation that your poster was accepted. The poster session and number assignments will be emailed one week before the Symposium.
Poster boards shall be available for display from 8am to 8pm the day of your assigned poster session. See the program agenda for the poster session schedule.
Every presentation at the Boulder Peptide Symposium is automatically recorded. Speakers are required to give consent for sharing of the presentation video with the peptide community.